查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球结核病诊断市场规模、份额和趋势分析：按最终用途、按类型、按地区、前景和预测，2024-2031 年
市场调查报告书
商品编码
1544268

全球结核病诊断市场规模、份额和趋势分析：按最终用途、按类型、按地区、前景和预测，2024-2031 年

Global Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Regional Outlook and Forecast, 2024 - 2031
出版日期: | 出版商: KBV Research | 英文 226 Pages | 订单完成后即时交付

价格

到 2031 年，结核病诊断市场规模预计将达到 30 亿美元，预测期内复合年增长率为 4.7%。

近年来，该领域取得了重要的技术进步，大大提高了结核病检测的准确性、速度和可及性。 GeneXpert MTB/RIF 检测是分子诊断改变结核病治疗的最突出的例子之一。因此，这些因素将推动市场成长。

然而，低收入和中等收入国家 (LMIC) 的许多卫生系统往往无法负担先进的结核病诊断工具，特别是基于分子诊断的工具。对捐赠资金的依赖也为结核病诊断的资金筹措带来了一定程度的不确定性和不稳定性。因此，先进结核病诊断工具的高成本，加上资金有限且不稳定，成为广泛采用这些技术的主要障碍。

此外，实验室设备、人员和财政拨款等资源也从结核病控制中转移到了应对这场流行病的迫切需求。这样做是因为世界各地的卫生系统无法应对 COVID-19 病例的增加。这种资源转移大大减少了结核病检测和诊断，因为许多结核病诊断设施已转移到 COVID-19 检测。因此，疫情对市场整体产生了负面影响。

最终用途展望

根据最终用途，市场分为诊断实验室、医院和诊所等。到 2023 年，医院和诊所部门将占据市场 35% 的收益占有率。医院和诊所是许多结核病患者的第一个接触点，对于早期诊断和开始治疗至关重要。

类型展望

根据类型，市场分为核酸检测、潜伏感染检测（皮肤试验和IGRA）、抗药性检测（DST）、噬菌体检测、细胞激素检测、诊断检测、放射学方法等。 2023 年，噬菌体检测领域占了 18% 的市场收益占有率。这种利用噬菌体检测结核分枝桿菌的方法因其能够提供快速、可靠的结果而引起了人们的关注。

区域展望

从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲/中东/非洲的市场进行了分析。 2023 年，亚太地区占据市场 35% 的收益占有率。该细分市场的成长是由印度、中国和印尼等国家的结核病高负担所推动的。这些国家占世界结核病病例的很大一部分，需要实施无所不在的持续结核病诊断。

目录

第一章 市场范围与调查方法

  • 市场定义
  • 目的
  • 市场范围
  • 分割
  • 调查方法

第二章 市场概况

  • 主要亮点

第三章市场概况

  • 介绍
    • 概述
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析

第四章全球市场：依最终用途分类

  • 全球诊断实验室市场：按地区
  • 全球医院和诊所市场：按地区
  • 世界其他市场：按地区

第五章世界市场：依类型

  • 全球潜伏感染检测（皮肤测试和 IGRA）市场（按地区）
  • 全球噬菌体检测市场：按地区
  • 全球抗药性检测（DST）市场：按地区
  • 全球核酸检测市场：按地区
  • 全球辐射法市场：按地区
  • 全球细胞激素检测分析市场：按地区
  • 全球诊断测试市场：按地区
  • 全球其他方式市场：按地区

第六章世界市场：按地区

  • 北美洲
    • 北美市场：按国家划分
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲市场：依国家分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 义大利
      • 其他欧洲国家地区
  • 亚太地区
    • 亚太市场：依国家分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉丁美洲/中东/非洲
    • 拉丁美洲/中东/非洲市场：依国家分类
      • 巴西
      • 阿根廷
      • 阿拉伯聯合大公国
      • 沙乌地阿拉伯
      • 南非
      • 奈及利亚
      • 其他拉丁美洲/中东/非洲地区

第七章 公司简介

  • Abbott Laboratories
  • Qiagen NV
  • Thermo Fisher Scientific, Inc
  • Becton, Dickinson, and Company
  • F Hoffmann-La Roche Ltd.
  • Hologic, Inc
  • Danaher Corporation
  • DiaSorin Sp.A
  • Bruker Corporation
  • Revvity, Inc

第 8 章：结核病诊断市场成功的基本条件

The Global Tuberculosis Diagnostics Market size is expected to reach $3 billion by 2031, rising at a market growth of 4.7% CAGR during the forecast period.

Despite having a lower TB incidence than other regions, North America's market is driven by advanced healthcare systems, high levels of awareness, and strong public health initiatives focused on TB elimination. The U.S., in particular, has made significant investments in TB research and development, leading to the availability of cutting-edge diagnostic technologies. Consequently, the North American region would acquire nearly 30% of the total market share by 2031.

Tuberculosis (TB) continues to be a substantial global health issue, with a particularly high incidence rate in developing countries. The impact of TB is not confined to health alone; it also has significant social and economic consequences. Hence, the rising incidence of TB will increase the demand for diagnostics, thereby propelling the expansion of the market.

Additionally, this field has witnessed significant technological advancements in recent years, which have been crucial in enhancing the accuracy, speed, and accessibility of TB detection. The GeneXpert MTB/RIF assay is one of the most prominent examples of molecular diagnostics transforming TB care. Thus, these factors will aid in the growth of the market.

However, Advanced TB diagnostic tools, particularly those based on molecular diagnostics, are often priced beyond the reach of many healthcare systems in low- and middle-income countries (LMICs). The reliance on donor funding also introduces a level of uncertainty and instability in the financing of TB diagnostics. Hence, the high cost of advanced TB diagnostic tools, coupled with limited and unstable funding, presents significant barriers to the widespread adoption of these technologies.

Moreover, in order to meet the urgent needs of the pandemic, resources such as laboratory facilities, personnel, and financial allocations were redirected from tuberculosis (TB) initiatives. This was done because healthcare systems all over the world were unable to cope with the rise of COVID-19 cases. This diversion of resources led to a significant decline in TB testing and diagnosis, as many TB diagnostic facilities were repurposed for COVID-19 testing. Hence, the pandemic had an overall negative impact on the market.

End Use Outlook

On the basis of end use, the market is classified into diagnostic laboratories, hospitals & clinics, and others. The hospitals & clinics segment garnered 35% revenue share in the market in 2023. Hospitals and clinics serve as the first point of contact for many TB patients, making them critical for the initial diagnosis and treatment initiation.

Type Outlook

Based on type, the market is divided into nucleic acid testing, detection of latent infection (skin test & IGRA), detection of drug resistance (DST), phage assay, cytokine detection assay, diagnostic laboratory methods, radiographic method, and others. The phage assay segment procured 18% revenue share in the market in 2023. This method, which utilizes bacteriophages to detect TB bacteria, has gained traction due to its ability to provide quick and reliable results.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment procured a 35% revenue share in the market in 2023. The segment's growth is driven by the high burden of tuberculosis in countries such as India, China, and Indonesia. This necessitates the implementation of ubiquitous and continuous TB diagnostics, as these countries are responsible for a substantial proportion of the global TB case count.

List of Key Companies Profiled

  • Abbott Laboratories
  • Qiagen N.V
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Revvity, Inc.

Global Tuberculosis Diagnostics Market Report Segmentation

By End Use

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

By Type

  • Detection of Latent Infection (Skin Test & IGRA)
  • Phage Assay
  • Detection of Drug Resistance (DST)
  • Nucleic Acid Testing
  • Radiographic Method
  • Cytokine Detection Assay
  • Diagnostic Laboratory Methods
  • Other Methods

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Tuberculosis Diagnostics Market, by End Use
    • 1.4.2 Global Tuberculosis Diagnostics Market, by Type
    • 1.4.3 Global Tuberculosis Diagnostics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Global Tuberculosis Diagnostics Market by End Use

  • 4.1 Global Diagnostic Laboratories Market by Region
  • 4.2 Global Hospitals & Clinics Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Tuberculosis Diagnostics Market by Type

  • 5.1 Global Detection of Latent Infection (Skin Test & IGRA) Market by Region
  • 5.2 Global Phage Assay Market by Region
  • 5.3 Global Detection of Drug Resistance (DST) Market by Region
  • 5.4 Global Nucleic Acid Testing Market by Region
  • 5.5 Global Radiographic Method Market by Region
  • 5.6 Global Cytokine Detection Assay Market by Region
  • 5.7 Global Diagnostic Laboratory Methods Market by Region
  • 5.8 Global Other Methods Market by Region

Chapter 6. Global Tuberculosis Diagnostics Market by Region

  • 6.1 North America Tuberculosis Diagnostics Market
    • 6.1.1 North America Tuberculosis Diagnostics Market by End Use
      • 6.1.1.1 North America Diagnostic Laboratories Market by Country
      • 6.1.1.2 North America Hospitals & Clinics Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Tuberculosis Diagnostics Market by Type
      • 6.1.2.1 North America Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.1.2.2 North America Phage Assay Market by Country
      • 6.1.2.3 North America Detection of Drug Resistance (DST) Market by Country
      • 6.1.2.4 North America Nucleic Acid Testing Market by Country
      • 6.1.2.5 North America Radiographic Method Market by Country
      • 6.1.2.6 North America Cytokine Detection Assay Market by Country
      • 6.1.2.7 North America Diagnostic Laboratory Methods Market by Country
      • 6.1.2.8 North America Other Methods Market by Country
    • 6.1.3 North America Tuberculosis Diagnostics Market by Country
      • 6.1.3.1 US Tuberculosis Diagnostics Market
        • 6.1.3.1.1 US Tuberculosis Diagnostics Market by End Use
        • 6.1.3.1.2 US Tuberculosis Diagnostics Market by Type
      • 6.1.3.2 Canada Tuberculosis Diagnostics Market
        • 6.1.3.2.1 Canada Tuberculosis Diagnostics Market by End Use
        • 6.1.3.2.2 Canada Tuberculosis Diagnostics Market by Type
      • 6.1.3.3 Mexico Tuberculosis Diagnostics Market
        • 6.1.3.3.1 Mexico Tuberculosis Diagnostics Market by End Use
        • 6.1.3.3.2 Mexico Tuberculosis Diagnostics Market by Type
      • 6.1.3.4 Rest of North America Tuberculosis Diagnostics Market
        • 6.1.3.4.1 Rest of North America Tuberculosis Diagnostics Market by End Use
        • 6.1.3.4.2 Rest of North America Tuberculosis Diagnostics Market by Type
  • 6.2 Europe Tuberculosis Diagnostics Market
    • 6.2.1 Europe Tuberculosis Diagnostics Market by End Use
      • 6.2.1.1 Europe Diagnostic Laboratories Market by Country
      • 6.2.1.2 Europe Hospitals & Clinics Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Tuberculosis Diagnostics Market by Type
      • 6.2.2.1 Europe Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.2.2.2 Europe Phage Assay Market by Country
      • 6.2.2.3 Europe Detection of Drug Resistance (DST) Market by Country
      • 6.2.2.4 Europe Nucleic Acid Testing Market by Country
      • 6.2.2.5 Europe Radiographic Method Market by Country
      • 6.2.2.6 Europe Cytokine Detection Assay Market by Country
      • 6.2.2.7 Europe Diagnostic Laboratory Methods Market by Country
      • 6.2.2.8 Europe Other Methods Market by Country
    • 6.2.3 Europe Tuberculosis Diagnostics Market by Country
      • 6.2.3.1 Germany Tuberculosis Diagnostics Market
        • 6.2.3.1.1 Germany Tuberculosis Diagnostics Market by End Use
        • 6.2.3.1.2 Germany Tuberculosis Diagnostics Market by Type
      • 6.2.3.2 UK Tuberculosis Diagnostics Market
        • 6.2.3.2.1 UK Tuberculosis Diagnostics Market by End Use
        • 6.2.3.2.2 UK Tuberculosis Diagnostics Market by Type
      • 6.2.3.3 France Tuberculosis Diagnostics Market
        • 6.2.3.3.1 France Tuberculosis Diagnostics Market by End Use
        • 6.2.3.3.2 France Tuberculosis Diagnostics Market by Type
      • 6.2.3.4 Russia Tuberculosis Diagnostics Market
        • 6.2.3.4.1 Russia Tuberculosis Diagnostics Market by End Use
        • 6.2.3.4.2 Russia Tuberculosis Diagnostics Market by Type
      • 6.2.3.5 Spain Tuberculosis Diagnostics Market
        • 6.2.3.5.1 Spain Tuberculosis Diagnostics Market by End Use
        • 6.2.3.5.2 Spain Tuberculosis Diagnostics Market by Type
      • 6.2.3.6 Italy Tuberculosis Diagnostics Market
        • 6.2.3.6.1 Italy Tuberculosis Diagnostics Market by End Use
        • 6.2.3.6.2 Italy Tuberculosis Diagnostics Market by Type
      • 6.2.3.7 Rest of Europe Tuberculosis Diagnostics Market
        • 6.2.3.7.1 Rest of Europe Tuberculosis Diagnostics Market by End Use
        • 6.2.3.7.2 Rest of Europe Tuberculosis Diagnostics Market by Type
  • 6.3 Asia Pacific Tuberculosis Diagnostics Market
    • 6.3.1 Asia Pacific Tuberculosis Diagnostics Market by End Use
      • 6.3.1.1 Asia Pacific Diagnostic Laboratories Market by Country
      • 6.3.1.2 Asia Pacific Hospitals & Clinics Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Tuberculosis Diagnostics Market by Type
      • 6.3.2.1 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.3.2.2 Asia Pacific Phage Assay Market by Country
      • 6.3.2.3 Asia Pacific Detection of Drug Resistance (DST) Market by Country
      • 6.3.2.4 Asia Pacific Nucleic Acid Testing Market by Country
      • 6.3.2.5 Asia Pacific Radiographic Method Market by Country
      • 6.3.2.6 Asia Pacific Cytokine Detection Assay Market by Country
      • 6.3.2.7 Asia Pacific Diagnostic Laboratory Methods Market by Country
      • 6.3.2.8 Asia Pacific Other Methods Market by Country
    • 6.3.3 Asia Pacific Tuberculosis Diagnostics Market by Country
      • 6.3.3.1 China Tuberculosis Diagnostics Market
        • 6.3.3.1.1 China Tuberculosis Diagnostics Market by End Use
        • 6.3.3.1.2 China Tuberculosis Diagnostics Market by Type
      • 6.3.3.2 Japan Tuberculosis Diagnostics Market
        • 6.3.3.2.1 Japan Tuberculosis Diagnostics Market by End Use
        • 6.3.3.2.2 Japan Tuberculosis Diagnostics Market by Type
      • 6.3.3.3 India Tuberculosis Diagnostics Market
        • 6.3.3.3.1 India Tuberculosis Diagnostics Market by End Use
        • 6.3.3.3.2 India Tuberculosis Diagnostics Market by Type
      • 6.3.3.4 South Korea Tuberculosis Diagnostics Market
        • 6.3.3.4.1 South Korea Tuberculosis Diagnostics Market by End Use
        • 6.3.3.4.2 South Korea Tuberculosis Diagnostics Market by Type
      • 6.3.3.5 Singapore Tuberculosis Diagnostics Market
        • 6.3.3.5.1 Singapore Tuberculosis Diagnostics Market by End Use
        • 6.3.3.5.2 Singapore Tuberculosis Diagnostics Market by Type
      • 6.3.3.6 Malaysia Tuberculosis Diagnostics Market
        • 6.3.3.6.1 Malaysia Tuberculosis Diagnostics Market by End Use
        • 6.3.3.6.2 Malaysia Tuberculosis Diagnostics Market by Type
      • 6.3.3.7 Rest of Asia Pacific Tuberculosis Diagnostics Market
        • 6.3.3.7.1 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use
        • 6.3.3.7.2 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type
  • 6.4 LAMEA Tuberculosis Diagnostics Market
    • 6.4.1 LAMEA Tuberculosis Diagnostics Market by End Use
      • 6.4.1.1 LAMEA Diagnostic Laboratories Market by Country
      • 6.4.1.2 LAMEA Hospitals & Clinics Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Tuberculosis Diagnostics Market by Type
      • 6.4.2.1 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.4.2.2 LAMEA Phage Assay Market by Country
      • 6.4.2.3 LAMEA Detection of Drug Resistance (DST) Market by Country
      • 6.4.2.4 LAMEA Nucleic Acid Testing Market by Country
      • 6.4.2.5 LAMEA Radiographic Method Market by Country
      • 6.4.2.6 LAMEA Cytokine Detection Assay Market by Country
      • 6.4.2.7 LAMEA Diagnostic Laboratory Methods Market by Country
      • 6.4.2.8 LAMEA Other Methods Market by Country
    • 6.4.3 LAMEA Tuberculosis Diagnostics Market by Country
      • 6.4.3.1 Brazil Tuberculosis Diagnostics Market
        • 6.4.3.1.1 Brazil Tuberculosis Diagnostics Market by End Use
        • 6.4.3.1.2 Brazil Tuberculosis Diagnostics Market by Type
      • 6.4.3.2 Argentina Tuberculosis Diagnostics Market
        • 6.4.3.2.1 Argentina Tuberculosis Diagnostics Market by End Use
        • 6.4.3.2.2 Argentina Tuberculosis Diagnostics Market by Type
      • 6.4.3.3 UAE Tuberculosis Diagnostics Market
        • 6.4.3.3.1 UAE Tuberculosis Diagnostics Market by End Use
        • 6.4.3.3.2 UAE Tuberculosis Diagnostics Market by Type
      • 6.4.3.4 Saudi Arabia Tuberculosis Diagnostics Market
        • 6.4.3.4.1 Saudi Arabia Tuberculosis Diagnostics Market by End Use
        • 6.4.3.4.2 Saudi Arabia Tuberculosis Diagnostics Market by Type
      • 6.4.3.5 South Africa Tuberculosis Diagnostics Market
        • 6.4.3.5.1 South Africa Tuberculosis Diagnostics Market by End Use
        • 6.4.3.5.2 South Africa Tuberculosis Diagnostics Market by Type
      • 6.4.3.6 Nigeria Tuberculosis Diagnostics Market
        • 6.4.3.6.1 Nigeria Tuberculosis Diagnostics Market by End Use
        • 6.4.3.6.2 Nigeria Tuberculosis Diagnostics Market by Type
      • 6.4.3.7 Rest of LAMEA Tuberculosis Diagnostics Market
        • 6.4.3.7.1 Rest of LAMEA Tuberculosis Diagnostics Market by End Use
        • 6.4.3.7.2 Rest of LAMEA Tuberculosis Diagnostics Market by Type

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Qiagen N.V.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Product Launches and Product Expansions:
    • 7.2.6 SWOT Analysis
  • 7.3 Thermo Fisher Scientific, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Product Launches and Product Expansions:
    • 7.3.6 SWOT Analysis
  • 7.4 Becton, Dickinson, and Company
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Partnerships, Collaborations, and Agreements:
    • 7.4.6 SWOT Analysis
  • 7.5 F. Hoffmann-La Roche Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Acquisition and Mergers:
    • 7.5.6 SWOT Analysis
  • 7.6 Hologic, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 SWOT Analysis
  • 7.7 Danaher Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 SWOT Analysis
  • 7.8 DiaSorin S.p.A.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expenses
    • 7.8.5 SWOT Analysis
  • 7.9 Bruker Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 SWOT Analysis
  • 7.10. Revvity, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expenses
    • 7.10.5 SWOT Analysis

Chapter 8. Winning Imperatives for Tuberculosis Diagnostics Market

LIST OF TABLES

  • TABLE 1 Global Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 2 Global Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 3 Global Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 4 Global Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 5 Global Diagnostic Laboratories Market by Region, 2020 - 2023, USD Million
  • TABLE 6 Global Diagnostic Laboratories Market by Region, 2024 - 2031, USD Million
  • TABLE 7 Global Hospitals & Clinics Market by Region, 2020 - 2023, USD Million
  • TABLE 8 Global Hospitals & Clinics Market by Region, 2024 - 2031, USD Million
  • TABLE 9 Global Others Market by Region, 2020 - 2023, USD Million
  • TABLE 10 Global Others Market by Region, 2024 - 2031, USD Million
  • TABLE 11 Global Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 12 Global Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 13 Global Detection of Latent Infection (Skin Test & IGRA) Market by Region, 2020 - 2023, USD Million
  • TABLE 14 Global Detection of Latent Infection (Skin Test & IGRA) Market by Region, 2024 - 2031, USD Million
  • TABLE 15 Global Phage Assay Market by Region, 2020 - 2023, USD Million
  • TABLE 16 Global Phage Assay Market by Region, 2024 - 2031, USD Million
  • TABLE 17 Global Detection of Drug Resistance (DST) Market by Region, 2020 - 2023, USD Million
  • TABLE 18 Global Detection of Drug Resistance (DST) Market by Region, 2024 - 2031, USD Million
  • TABLE 19 Global Nucleic Acid Testing Market by Region, 2020 - 2023, USD Million
  • TABLE 20 Global Nucleic Acid Testing Market by Region, 2024 - 2031, USD Million
  • TABLE 21 Global Radiographic Method Market by Region, 2020 - 2023, USD Million
  • TABLE 22 Global Radiographic Method Market by Region, 2024 - 2031, USD Million
  • TABLE 23 Global Cytokine Detection Assay Market by Region, 2020 - 2023, USD Million
  • TABLE 24 Global Cytokine Detection Assay Market by Region, 2024 - 2031, USD Million
  • TABLE 25 Global Diagnostic Laboratory Methods Market by Region, 2020 - 2023, USD Million
  • TABLE 26 Global Diagnostic Laboratory Methods Market by Region, 2024 - 2031, USD Million
  • TABLE 27 Global Other Methods Market by Region, 2020 - 2023, USD Million
  • TABLE 28 Global Other Methods Market by Region, 2024 - 2031, USD Million
  • TABLE 29 Global Tuberculosis Diagnostics Market by Region, 2020 - 2023, USD Million
  • TABLE 30 Global Tuberculosis Diagnostics Market by Region, 2024 - 2031, USD Million
  • TABLE 31 North America Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 32 North America Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 33 North America Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 34 North America Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 35 North America Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 36 North America Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 37 North America Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 38 North America Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 39 North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 40 North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 41 North America Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 42 North America Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 43 North America Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 44 North America Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 45 North America Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 46 North America Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 47 North America Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 48 North America Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 49 North America Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 50 North America Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 51 North America Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 52 North America Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 53 North America Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 54 North America Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 55 North America Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 56 North America Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 57 North America Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 58 North America Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 59 North America Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 60 North America Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 61 US Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 62 US Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 63 US Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 64 US Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 65 US Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 66 US Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 67 Canada Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 68 Canada Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 69 Canada Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 70 Canada Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 71 Canada Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 72 Canada Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 73 Mexico Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 74 Mexico Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 75 Mexico Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 76 Mexico Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 77 Mexico Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 78 Mexico Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 79 Rest of North America Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 80 Rest of North America Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 81 Rest of North America Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 82 Rest of North America Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 83 Rest of North America Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 84 Rest of North America Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 85 Europe Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 86 Europe Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 87 Europe Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 88 Europe Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 89 Europe Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 90 Europe Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 91 Europe Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 92 Europe Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 93 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 94 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 95 Europe Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 96 Europe Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 97 Europe Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 98 Europe Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 99 Europe Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 100 Europe Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 101 Europe Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 102 Europe Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 103 Europe Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 104 Europe Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 105 Europe Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 106 Europe Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 107 Europe Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 108 Europe Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 109 Europe Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 110 Europe Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 111 Europe Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 112 Europe Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 113 Europe Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 114 Europe Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 115 Germany Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 116 Germany Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 117 Germany Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 118 Germany Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 119 Germany Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 120 Germany Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 121 UK Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 122 UK Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 123 UK Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 124 UK Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 125 UK Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 126 UK Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 127 France Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 128 France Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 129 France Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 130 France Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 131 France Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 132 France Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 133 Russia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 134 Russia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 135 Russia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 136 Russia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 137 Russia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 138 Russia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 139 Spain Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 140 Spain Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 141 Spain Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 142 Spain Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 143 Spain Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 144 Spain Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 145 Italy Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 146 Italy Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 147 Italy Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 148 Italy Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 149 Italy Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 150 Italy Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 151 Rest of Europe Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 152 Rest of Europe Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 153 Rest of Europe Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 154 Rest of Europe Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 155 Rest of Europe Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 156 Rest of Europe Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 157 Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 158 Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 159 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 160 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 161 Asia Pacific Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 162 Asia Pacific Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 163 Asia Pacific Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 164 Asia Pacific Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 165 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 166 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 167 Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 168 Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 169 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 170 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 171 Asia Pacific Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 172 Asia Pacific Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 173 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 174 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 175 Asia Pacific Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 176 Asia Pacific Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 177 Asia Pacific Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 178 Asia Pacific Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 179 Asia Pacific Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 180 Asia Pacific Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 181 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 182 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 183 Asia Pacific Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 184 Asia Pacific Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 185 Asia Pacific Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 186 Asia Pacific Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 187 China Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 188 China Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 189 China Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 190 China Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 191 China Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 192 China Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 193 Japan Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 194 Japan Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 195 Japan Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 196 Japan Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 197 Japan Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 198 Japan Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 199 India Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 200 India Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 201 India Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 202 India Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 203 India Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 204 India Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 205 South Korea Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 206 South Korea Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 207 South Korea Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 208 South Korea Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 209 South Korea Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 210 South Korea Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 211 Singapore Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 212 Singapore Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 213 Singapore Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 214 Singapore Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 215 Singapore Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 216 Singapore Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 217 Malaysia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 218 Malaysia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 219 Malaysia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 220 Malaysia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 221 Malaysia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 222 Malaysia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 223 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 224 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 225 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 226 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 227 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 228 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 229 LAMEA Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 230 LAMEA Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 231 LAMEA Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 232 LAMEA Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 233 LAMEA Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 234 LAMEA Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 235 LAMEA Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 236 LAMEA Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 237 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 238 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 239 LAMEA Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 240 LAMEA Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 241 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 242 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 243 LAMEA Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 244 LAMEA Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 245 LAMEA Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 246 LAMEA Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 247 LAMEA Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 248 LAMEA Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 249 LAMEA Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 250 LAMEA Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 251 LAMEA Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 252 LAMEA Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 253 LAMEA Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 254 LAMEA Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 255 LAMEA Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 256 LAMEA Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 257 LAMEA Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 258 LAMEA Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 259 Brazil Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 260 Brazil Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 261 Brazil Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 262 Brazil Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 263 Brazil Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 264 Brazil Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 265 Argentina Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 266 Argentina Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 267 Argentina Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 268 Argentina Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 269 Argentina Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 270 Argentina Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 271 UAE Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 272 UAE Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 273 UAE Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 274 UAE Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 275 UAE Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 276 UAE Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 277 Saudi Arabia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 278 Saudi Arabia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 279 Saudi Arabia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 280 Saudi Arabia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 281 Saudi Arabia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 282 Saudi Arabia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 283 South Africa Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 284 South Africa Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 285 South Africa Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 286 South Africa Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 287 South Africa Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 288 South Africa Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 289 Nigeria Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 290 Nigeria Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 291 Nigeria Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 292 Nigeria Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 293 Nigeria Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 294 Nigeria Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 295 Rest of LAMEA Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 296 Rest of LAMEA Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 297 Rest of LAMEA Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 298 Rest of LAMEA Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 299 Rest of LAMEA Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 300 Rest of LAMEA Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 301 Key Information - Abbott Laboratories
  • TABLE 302 Key Information - Qiagen N.V.
  • TABLE 303 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 304 Key Information - Becton, Dickinson and Company
  • TABLE 305 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 306 Key Information - Hologic, Inc.
  • TABLE 307 Key Information - Danaher Corporation
  • TABLE 308 Key Information - DiaSorin S.p.A.
  • TABLE 309 Key Information - Bruker Corporation
  • TABLE 310 Key Information - Revvity, Inc.